Delivery Order SPE2DB20D7061-SPE2DB25FSNR9

Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,924,778 units of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The order has a ceiling value of $1,445.28 and is a firm fixed-price contract. The ultimate completion date for this delivery order is September 25, 2024. This award is not a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,286,403 units of cefazolin, an antibiotic medication, with a ceiling value of $7,780.50. The contract is a firm fixed-price type with a period of performance through May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a Firm Fixed Price Delivery Order for the supply of cefazolin 2 g/50 ml-dextrose medical products. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $4,335.84 and an ultimate completion date of August 13, 2024. It is a firm fixed-price contract, with no set-aside designation....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical distributor. The $1,979.10 order is for the supply of Cefazolin 2 g/50 mL-dextroses, a specialty pharmaceutical product, in support of military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award, SPE2DB22D3009|SPE2DB25FAH17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083.96 firm fixed-price delivery order is for the supply of 4,566,196,865 units of the antibiotic medication Cefazolin 2 g/50 ml-dextrose. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,550 units of the pharmaceutical product Cefazolin 2 g/50 mL-Dextroses. The contract, valued at $7,257.47, has an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,529.24 firm fixed-price contract is for the supply of cefazolin 2 g/50 ml dextrose, a critical intravenous antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order worth $4,335.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The order is for the supply of 4565633467 Cefazolin 2 g/50 mL-Dextroses, a critical care medical product. The contract has a firm-fixed price pricing type and a period of performance through August 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,337.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,742,874 units of Cefazolin 1 g/50 ml-dextrose, a critical antibiotic medication used in various medical treatments. The contract is a Firm Fixed Price Delivery Order with a completion date of July 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSNR9
    Delivery Order

This is a $4,319.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 1 G/50 ML-Dextroses, a type of antibiotic medication, with a period of performance through July 7, 2025.

Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The current $4,319.60 delivery order is not set aside and was awarded through open competition.

Generated 10/5/25, 1:02 AM